Rising Glucose Demand Pads Bottom Line Of Shengtai Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Shengtai Pharmaceutical's net profit for the fourth quarter of 2007 rose by 97 percent year-on-year to $3.1 million, as a result of robust sales of pharmaceutical-grade glucose products, Shengtai CFO Philips Zhang told investors during a second-quarter earnings call Feb. 15
You may also be interested in...
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required.)